Rugo HS, Dieras V, Cortes J, Patt D, et al. Real-world survival outcomes of heavily pretreated patients with refractory HR+, HER2-metastatic breast cancer receiving single-agent chemotherapy-a comparison with MONARCH 1. Breast Cancer Res Treat 2020 Aug 12. pii: 10.1007/s10549-020-05838.
PMID: 32789591